CRISPR Therapeutics
CRSP
#3011
Rank
A$7.74 B
Marketcap
A$80.70
Share price
-0.52%
Change (1 day)
37.03%
Change (1 year)

Quarterly Reports

Thumbnail CRISPR Therapeutics Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail CRISPR Therapeutics Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail CRISPR Therapeutics Quarterly Report 2024-q3

Quarterly Report 2024-q3

Language: English

View Quarterly Report
Thumbnail CRISPR Therapeutics Quarterly Report 2024-q2

Quarterly Report 2024-q2

Language: English

View Quarterly Report
Thumbnail CRISPR Therapeutics Quarterly Report 2016-q3

Quarterly Report 2016-q3

Language: English

View Quarterly Report